A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/415 (2006.01) C07D 233/02 (2006.01) C07D 233/04 (2006.01) C07D 409/06 (2006.01)
Patent
CA 2299470
This invention relates to (E)-.alpha.-[2-n-butyl-1-[(4-carboxyphenyl)methyl)- 1H-imidazol-5-yl]methylene-2-thiophenepropionic acid arginyl charge-neutralization-complex, a process for its production, compositions containing the compound and methods of using the compound to block angiotensin II receptors and to treat hypertension, congestive heart failure and renal failure.
L'invention concerne un complexe à neutralisation de charge de L-arginine d'acide (E)- alpha -[2-n-butyl-1-[(4-carboxyphényl)méthyl]-1H-imidazol-5-yl]méthylène-2-thiophènepropionique, son procédé de production, des compositions renfermant ce composé, et des procédés d'utilisation de ce composé visant à bloquer les récepteurs de l'angiotensine II et à traiter l'hypertension, l'insuffisance cardiaque globale, et l'insuffisance rénale.
Gudipati Manga R.
Jushchyshyn John M.
Palepu Nageswara R.
Venkatesh Gopadi M.
Glaxosmithkline Llc
Gowling Lafleur Henderson Llp
Smithkline Beecham Corporation
LandOfFree
Eprosartan arginyl charge-neutralization-complex and a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Eprosartan arginyl charge-neutralization-complex and a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Eprosartan arginyl charge-neutralization-complex and a... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1544752